AMY MCCLOSKEY: Open Payments
NPI 1487189072 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$207 in 10 payments from 8 companies in 2025. Trend: 2023 $158 · 2024 $159 · 2025 $207
Food & beverage: $207
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $22 |
| Stemline Therapeutics Inc. | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $21 |
| Celgene Corporation | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: CABLIVI, ZYNLONTA, Orserdu, RYBREVANT, REBLOZYL, Nubeqa, PLUVICTO, LUTATHERA.
Industry payments across GA — which companies pay providers there.
